women Archives - Green Market Report

Julie AitchesonAugust 5, 2021


In every sector of culture and society, a shift towards greater diversity is moving the needle on what, and who is considered “typical”. This is as true in the realm of cannabis consumption as anywhere else, with the stereotype of surfer dude stoners and glazed and confused couch potatoes making way for women as the fastest-growing segment of cannabis consumers. Manufacturers are paying close attention to what these women want and how best to reach them with thoughtful branding, high levels of customer service, product design, and the retail experience. Not only are women increasingly driving cannabis sales, but they are also shifting their consumer behavior in ways that are pushing the industry to get more creative and innovative in meeting their demands—a trend that cannabis technology company Akerna (NASDAQ: KERN) highlights in its mid-year report.

According to Akerna’s report, “Since 2019, females have steadily increased their percentage of sales, a total of 3.2%. While that may seem like a low number, it’s actually a significant change considering the vast numbers of cannabis consumers – over 15 million have purchased in 2021 so far.”  Their market share, which in 2019 was 35% is now 38.2% and growing. Additionally, for the first time ever, concentrates have overtaken edibles in popularity among younger women, a change attributed to decreased stigma and increased consumer education. Previously, edibles held third place in female product preferences with concentrates in fourth, but that has changed since 2020 with 10.2% of women reporting a preference for concentrates over 8.9% who prefer edibles. Flower is still the favorite product among female consumers with 44% still ranking it their top choice, but the industry is watching this closely as new product innovations inspire new allegiances.

In Akerna’s report, 27.53% of female consumers fall into the under 30 category and 29.40% are between 30 and 40 years old, with both demographics preferring flower, cartridges, and concentrates in that order. Both age categories placed infused edibles and “Other” in fourth and fifth place. For these women, cartridges lead concentrates by 20% or more, with edibles roughly half as popular as concentrates. Edibles still beat out concentrates for the 13.6% of female purchasers in the 50-60 age range and the 10.33% falling into the 60+ category. The strongest showing for edibles was in the oldest demographic (60+ women) studied, with 18.39% preferring edibles and only 5.31% concentrates. 

The trend in younger consumers leaning more towards concentrates and elders remaining loyal to edibles holds up in the male demographic as well, though this isn’t attracting as much notice from the industry as the rise of women consumers. Although Akerna’s mid-year report has men still accounting for 61.8% of cannabis sales, women are closing that gap at a steady pace and challenging the industry to up its game in order to compete for their business.

Debra BorchardtApril 14, 2021


 Green Market Report asked these female cannabis executives what advice they could give to other women on the eve of another 420 holiday. These were their answers:

Kimberly Dillion, Founder CEO of Frigg

  • “The key is community. More than ever being connected to other women at all levels is so instrumental for the success of all of us. By having strong networks we can amplify other voices, source deals, tackle wrongs, mentor others, collectively call out bad actors, and let’s not forget also have fun with our favorite plant!”

Amy Cirincione O’Connor, Co-Founder and Head of People Officer at Humboldt Social.

  • A female farmer I work with told me recently, “Surround yourself with people who move the chair.”  Not the people who walk through the room, notice a chair is blocking the doorway, and walk around it; the people who see the chair is a problem, and take the opportunity to solve the problem. I have no patience for meetings in which people complain or talk to just to hear their own voices. I like to work with people who are solution-oriented, who feel invested in creatively solving problems. I like working with people who move chairs.

Karson Humiston, Founder & CEO of Vangst

  • “Surround yourself with women you can learn from. Women are so supportive of each other and genuinely want to help other women succeed; find mentors”

Mary Pryor, Cannaclusive, Co-Founder

  • “Women are clutch and a powerful audience that cannabis often underestimates. We need more voices and diverse strategies that aid in educating and getting people to become fans of the plant. I find that this industry doesn’t open its self to understanding our use cases and issues when it comes to health in the cannabis world. We need to figure out ways to drive our value and reach within in this space when it comes to employment and c-suite as well.”

Lauren Drury, B2B Marketing Director, Greenlane

  • “We’re not following a path, we’re blazing it. In most industries, you can seek out an answer, but in cannabis, you have to create it!”

Azia Weisz, Senior Director of Sales and Marketing, Greenlane

  • “Goals are a moving target in the cannabis industry, it’s important to always be flexible to pivot and patient with process development.”

StaffMay 18, 2020


Editors Note: This article was republished with permission from Martin Lee and the www.projectcbd.org website.

Many scientists don’t have big public relations teams to promote their work or work at companies that employ marketing efforts to make their achievements known. Instead, they toil away in labs, most unrecognized for their hard work. Green Market Report is happy to give these women the accolades they deserve.


Allyn Howlett, PhD, is a pioneer neuropharmacologist known for her groundbreaking discovery of the CB1 cannabinoid receptor in 1988. Initially identified by Howlett and her graduate student, William Devane, at the St. Louis School of Medicine, CB1 receptors are the most abundant G-protein coupled receptors in the mammalian brain. This discovery opened the floodgates of research into the endocannabinoid system with huge implications for nearly every area of medical science. Howlett is currently a professor in the Department of Physiology and Pharmacology at the Wake Forest School of Medicine in Winston-Salem, North Carolina, where the Howlett Lab is studying protein interactions that modulate cannabinoid receptor activity in an effort to advance the development of new cannabinoid medicines. Read more here.


Cecilia Hillard, PhD, is the Associate Dean for Research and Director of the Neuroscience Research Center at the Medical College of Wisconsin in Milwaukee, where her lab focuses on the pharmacology and biochemistry of cannabinoids and endocannabinoids. Her work has contributed significantly to understanding how cannabinoids regulate immune function and the role of endocannabinoid signaling in the regulation of mood and responses to stress. An outstanding mentor to medical students and scientists, Hillard is the recipient of many honors, including the Lifetime Achievement Award from the International Cannabinoid Research Society (ICRS). She currently serves as executive director of the ICRS.



Heather Bradshaw, PhD, is an Associate Professor in the Department of Psychological & Brain Sciences at Indiana University in Bloomington, where she directs the Bradshaw Lab of Lipid Neuroscience. Her studies focus on how endocannabinoids and related lipid molecules impact female reproductive neurophysiology. Bradshaw’s team is examining disease models of endometriosis, chronic pain, and neuroinflammation and their link to aberrant lipid signaling in the endocannabinoid system. A past president of the International Cannabinoid Research Society, Bradshaw has published over sixty journal articles and frequently lectures at universities and conferences around the world.



Andrea Hohmann, PhD, is chairwoman of the Gill Center for Biomolecular Science at Indiana University in Bloomington. One of the world’s foremost experts on neuropathic pain and the endocannabinoid system, Hohmann is seeking to develop novel therapeutic interventions for promoting analgesia that lack abuse liability and adverse side effects. Hohmann’s lab has demonstrated that nonopioid stress-induced analgesia is mediated by the release of endocannabinoids. In addition to mapping cannabinoid receptors within pain pathways, she has been researching the potential benefits of administering cannabinoids and opioids in combination. Hohmann and her colleagues have shown that activating the CB2 cannabinoid receptor can prevent opioid tolerance and reduce symptoms of opioid withdrawal.



Cristina Sánchez, PhD, is a Spanish molecular biologist who has been at the forefront of researching cannabinoids as nontoxic chemotherapeutic agents for cancer. Her trailblazing studies at the Complutense University of Madrid have documented the antitumoral and antiproliferative properties of tetrahydrocannabinol (THC) and cannabidiol (CBD). Sánchez was among the first scientists to report on the ability of cannabinoids to destroy cancer cells without harming healthy cells. Her recent work focusing on THC and breast cancer adds to the growing body of research that validates the therapeutic attributes of whole plant cannabis oil extracts.



Patricia Reggio, PhD, is a leader in the field of computational chemistry and computer-aided drug design. Professor Reggio’s research group at the University of North Carolina in Greensboro has been at the forefront of probing the structural basis of cannabinoid receptor activity, including “allosteric” docking sites that can modulate how a receptor signals. Her team has identified endogenous ligands for newly discovered orphan receptors that also bind to plant cannabinoids. A major focus of Reggio’s work entails targeted biomolecular modeling using computational chemistry for drug design.





Linda Parker, PhD, is Professor in the Psychology and Collaborative Neuroscience Program and Canada Research Chair in Behavioral Neuroscience at the University of Guelph in Ontario. She is the author of Cannabinoids and the Brain (MIT Press, 2017) and a recipient of the Lifetime Achievement Award from the International Cannabinoid Research Society. Parker’s lab is investigating neural activity involved in the modulation of the pharmacological properties of drugs, with specific applications for controlling nausea and vomiting in humans. Her cannabinoid research cuts across the traditional boundaries of psychology, pharmacology, and neurobiology to elucidate processes of learning, emotion, sickness, and addiction.



Michelle Glass, PhD, is Head of the Department of Pharmacology and Toxicology at the University of Otago in New Zealand. Her research focuses on the expression, function, and molecular pharmacology of cannabinoid receptors and their potential role in treating neurodegenerative diseases. Glass and her colleagues have identified the mechanisms by which synthetic cannabinoids confer toxic and, in some cases, lethal outcomes. Professor Glass, a former president of the ICRS, is a member of the Medical Cannabis Research Collaborative in New Zealand, which is helping government regulators devise and implement standards for the development and testing of medical cannabis products.



Saoirse O’Sullivan, PhD, specializes in researching cannabinoid pharmacology and the therapeutic potential of cannabis-based medicines. She was formerly an Associate Professor at the University of Nottingham in the UK, where her research methodologies encompassed cellular and animal models, as well as volunteer studies and early phase clinical trials. O’Sullivan’s specific areas of expertise include the cardiovascular and gastrointestinal effects of CBD and other cannabinoids. In 2016, she was named the International Cannabinoid Research Society Young Investigator of the year, and in 2017 she launched her own company, CanPharmConsulting.




Mary Abood, PhD, is a Professor of Anatomy and Cell Biology at Temple University in Philadelphia. Her lab cloned the CB1 and CB2 receptors and elucidated the molecular mechanisms of cannabinoid receptor signaling. Abood and her team have published numerous papers on the role of cannabinoids in exitotoxicity and neurodegenerative diseases, such as ALS. More recently, Abood has focused on identifying novel cannabinoid receptor subtypes. This research has led to the discovery of a series of “orphan receptors” – GPR18GPR35GPR55, etc. – that regulate inflammation, metabolism, and cellular homeostasis. CBDTHC, and endogenous cannabinoids bind to these orphan receptors.

StaffMarch 6, 2020


In honor of International Women’s Day, we are releasing our annual “Most Important Women in Weed” list for 2020. This list includes women in the industry that have collectively moved the industry forward with all of their hard work, continuous dedication and effort.

This year we opened up the list for nominations and received almost a thousand nominees. After consideration of each, we have developed what we feel is one of the most inclusive and carefully curated lists of the most accomplished and impressive women in the cannabis industry.

As we could not name them all, we would like to thank and celebrate all of the women who have dedicated their precious time to the advancement of cannabis globally.

It is because of each one of these ladies that this industry remains in the lead above all others as far as female leadership is concerned.

This list is in no special order. Each one of these women provide a great contribution to the cannabis industry in their own unique and badass way.

Thank you to every one of you for all that you do!

The “List”

Dr. Chanda Macias

Yvonne DeLaRosa Green

Mara Gordon

Rosie Mattio

Shawna McGregor

Lori Ferrara

Gaynell Rogers

Stormy Simon

Trista Okel 

Lori Ajax

Amy Dawn Bourlon-Hilterbran

Kim Rivers

Amanda Soens

Dona Frank

Kat King

Sara Payan

Hannah Daphna

Sandra Castaneda

Erin Gore

Wendy Kornberg

Kristin Nevedal

Wendy Turner

Parisa Rad

Brittany Nicholson

Emily Paxhia

Jessica Billingsley 

Gia Moron

Andrea Brooks

Tahira Rehmatullah

Tracey Mason

Lindy Snyder

Jasmine Rose Gunderson

Shannon Hattan

Adelia Carrillo

Karen Petersen

Wanda James

Barbara Blaser

Ophelia Chong

Amanda Ostrowitz

Pamela Nicole Epstein

Melissa Mentele

Jamie Cooper

Sarah Remesch

Jessie Gill

Erica Daniels

Lizzy Jeff

Lelehnia DuBois

Whitney Beatty

Dr. Michele Ross

Manndie Tingler

Chef Lauren Gockley

Kyra Reed

Jamie Evans

Kristin Jordan

Ellie Siegel 

Sara Brittany Somerset

Linda Marsicano

Heidi Groshelle

Amber Senter

Nique Pichette

Jennifer Price

Molly Peckler 

Bonita Money

Susan Hwang

Judy Yee

Julie Chiarello

Leah Heis

Leslie Andrachuk

Terra Carver

Nancy Whiteman

Luna Stower

Karen Paull and Wendy Robbins

Beth Stavola

Alison Gordon

Penny Green

Sara Gullickson

Dr. Lakisha Jenkins

Pamela Hadfield

Jessica Peters

Dr. Rachel Knox and Dr. Jessica Knox

Tiffany Bowden

Mary Jane Gibson

Michelle Janikian

Dr. Uma Dhanabalan

Taylor Blake

AC Braddock

Kerri Accardi

Heather Sobel

Betty Aldworth

Cathy Jordan

Suzanne Sisley

Nina Parks

Eliza Nova Maroney

Selena Xochitl Martinez

Angelika Penuela-Ruiz

Sarah Mitra Payan

Gretchen Gailey

Nikki Lastreto

Ann Lawrence

Sheena Shiravi

Christina Ianuzzi

Kassandra Frederique

Shannon Buyers

Celia Tapp

Kelly Archer

Katie Field

Randi Sether

Shannon Reed

Katrina Yolen

Ngiste Abebe

Brooke Westlake

Courtney Maltais

Katrina Tso

Anne Don0hoe

Alicia Rose Kelley

Dr. Jacqueline Harding, PhD 

Mary Pryor 

Dr. Uma Dhabalan

Olivia Mannix

Heather DeRose

Libby Cooper

Leslie Hoffman

Yvonne Perez Emerson


Again, thank you to all of the women who do so much in our industry day in and day out. Your work does not go unnoticed and is deeply appreciated.

Happy International Women’s Day to all women around the world!

Special shout out to our Green Market Report co-founders Debra Borchardt and Cynthia Salarizadeh on this day!

Anne-Marie FischerDecember 20, 2019


“It’s important to have data about women’s experiences in cannabis because we need to have an understanding of the baseline of how women are experiencing working in this industry,” said Jennifer Whetzel of Ladyjane Branding when we caught up with her about the recent launch of the Women in Cannabis Study.

Whetzel, along with Wolfe Research & Consulting has taken on this ambitious longitudinal study that seeks to examine the experiences of women in cannabis across the globe. “Once we have a baseline, then we can figure out what we need to do to make this a more inclusive industry,” says Whetzel.

This study digs deep. From barriers to entry and success to the experiences of sexual harassment and discrimination, to whether they feel that cannabis is an equitable industry, this study seeks to blow all we know, and believe, about experiences of women in cannabis out of the water.

Much like a lot of the research in the cannabis industry, anecdotal data has ruled. In some ways, the lack of clinical research in cannabis has gotten us away from valuing qualitative data when looking for insights into particular issues in the cannabis industry.

“By asking these questions in a scientific way following established research methodology, then we can transform what would be viewed as an anecdote into data,” said Dr. Nicole Wolfe of Wolfe Research & Consulting, “We can then take that data, analyze it and present it in a way that provides real information and a real understanding of the landscape. That’s what is needed by business leaders, stakeholders, decision-makers and policymakers to create change, or motivate changes in behavior.”

The study leaders have a goal of collecting a minimum of 300 responses to start their official reporting and research dissemination strategy, having reached half that goal already (150 respondents), less than 10 days after the official launch. The overall goal is to collect over 1,000 responses. The study is set up to collect both quantitative and qualitative data that can be coded to provide more concrete data based on women’s stories and insights.

We asked Whetzel for a peek into some of the data that the study has collected so far. Here are some of their findings:

Treatment of Women of the Industry

Of the 150 respondents, 67% believe that women are not treated equitably in the cannabis industry, with 66% of respondents saying that they feel they are taken less seriously because they are a woman. 51% of respondents have experienced a lack of support or bullying within the cannabis industry. In particular, respondents identified a lack of support and bullying from other women as a specific concern. In Whetzel’s reflection on this data, she suggests that “maybe we need to learn better skills and how to work and live with compassion.”

Barriers to Entry

The study asked participants to identify the barriers to entry that they have identified when trying to break into the cannabis industry. “Being taken seriously” is the sentiment that is leading the barriers to entry pack, with “Obtaining resources and funding” coming up as a close second. In order, the other barriers to entry that were ranked include:

  • Balancing personal and professional life
  • Low pay
  • Discrimination and lack of respect
  • Finding the right position
  • Fear of failure

Undervaluing Time and Efforts

It’s common for women in cannabis to undercharge or undervalue their time and contributions. In fact, 73% of the respondents say that undercharging or undervaluing their time has negatively impacted them professionally, and have identified the development of negotiation skills as a necessary tool for them to move forward professionally. Most women identified that having an industry mentor would be helpful for their development, but also identified that there is a lack of formalized programs or avenues for obtaining a mentor.

Identifying a Significant Gap

Among the things that have most surprised Whetzel and Wolfe is the overwhelming response from women who identify as White, with 70% identifying as heterosexual. “The majority of the respondents are white CEOs and business owners. That will not tell us the whole story,” says Whetzel. “We need at least a thousand surveys from a diverse audience so that we can drill down into the data to compare the experiences of women across marginalized communities.”

Marijuana Business Daily released its annual “Women and Minorities Report” earlier this year that indicated that at least 51% of the cannabis industry is owned and controlled by racial minorities. Whetzel recognizes that we need to capture these audiences as well, and hopes that the study will be adopted by BIPOC  groups, the LGBTQ community, and other special interest and niche groups within the cannabis space.

Get Involved

The study is only just beginning. Considered “a living history”, the study will remain open until January 10, or until they have received the minimum number of respondents to begin reporting. At that time, the researchers will set a strategy for reaching more diverse audiences. The research dissemination strategy includes social media, thoughtfully produced videos, a quarterly report, and an annual report.

To participate in the study, visit: https://womenincannabis.study/

The study partners are also accepting sponsorships and partnerships to help this study move forward, collect more responses, and increase the budget for qualitative interviews. “We only budgeted for twenty-five qualitative interviews and so far a hundred have raised their hand asking to tell their story in more detail,” says Whetzel. “We need sponsors and supporters to help pay to interview, transcribe and analyze the data.”

Visit https://womenincannabis.study/ to get involved as a participant, study partner, or sponsor.

What are Whetzel’s hopes for this study? “By collecting data and creating knowledge on this topic, the study will help to determine the education, policies, procedures and actionable recommendations that can help make the industry a welcoming space for everyone.”

The goal is to repeat this study on an annual basis so that the researchers can track the progress of the initiatives to create change in the industry. Future plans include an examination of “allyship”, particularly how men support women’s growth and development within the industry.

Be a part of living history and be the change you want to see for women in the cannabis industry.




Video StaffMay 30, 2019


The Economics of Cannabis & Women-led Businesses panel was held on May 7 at the Green Market Summit in Chicago. Women lead almost 30% of the businesses in cannabis and the opportunities are there. The group of distinguished women reviews the best sectors to build a business and how to obtain the capital for your company to thrive and grow. The moderator was Lori Ferrara, Founder -Treehouse Ventures is joined by Tracy Mason, Chief Strategy & Innovation Officer – Cannacraft, Tahira Rehmatullah, CEO – MTech and Amy Margolis, Founder – The Initiative

Debra BorchardtMarch 25, 2019


The only female member of NYMCIA President Hillary Peckam Resigns as President of the Cannabis Organization.

Full legalization in New York State seems to have hit a road bump. What looked like a done deal when Governor Cuomo said he wanted to see some legislation this year, now looks as if it could be stalled. Supposedly a disagreement over diversity amongst the licensees has caused some politicians in Albany to push back. New York State Assembly member Crystal Peoples-Stokes has stated that her position is that adult-use marijuana will not be implemented in New York State if it is not inclusive of equity.

The New York Medical Cannabis Industry Association (NYMCIA) seems to agree in principle, but the actions taken by the state and by the NYMCIA spell a different story altogether. Hillary Peckham, the only women-led licensed cannabis operator in the state recently resigned as President of the organization. Her company Etain Health is on the endangered list of cannabis companies in the state and it seems the state has made no serious moves to make sure that the only woman-owned company survives. It makes public statements that it wants to make sure there is diversity, but the actions the state actually makes are just the opposite. Peoples-Stokes and New York State Senator Andrea Stewart-Cousins, both supporters of diversity in cannabis did not respond for a request to comment.

The First Five

Etain is one of the original five licensees in New York and remains a family-owned business. It is the only female-led company in the state. Most of the original five have been bought out by larger multi-state operators known as MSO’s. Many were forced into that situation because the laws in New York’s medical marijuana program were so restrictive that patients didn’t sign up. It’s not cheap to run a cannabis company, much less one that has few patients to service. The hope for the original five was that they would be well positioned to become recreational operators one day.

Then the state decided that five licensees weren’t enough, even though those five were barely surviving and expanded the group to ten. Now the state is considering legalizing adult use cannabis and it looks as if it is considering a competitive bidding process -including an auction in order to get recreational licenses. The existing medical license holders will have to compete with others resulting in the pioneers receiving little advantage for blazing a trail as settlers come swooping in.

While the number hasn’t been confirmed, Peckham said the auction fee is expected to be quite high. That is based on a comment from one of the New York politicians who said that the $10 million that California asked for was “too low.” Peckham said that amount would be almost impossible for Etain to raise and if she doesn’t get a recreational license, it is pretty much game over.

The auction fees are intended to be used to pay for the department that will oversee the marijuana program and possibly provide incubator money and loans for minority and women-owned businesses. Peckham noted the hypocrisy of borrowing money from the department you’ve just funded through auction fees.

Just Raise The Money!

Every day there are headlines about cannabis companies raising millions of dollars, so the general response to Etain’s complaint about the potentially high cost of entering the auction is met with the response to ‘just to raise some money.’ Peckham explains the problems with that simplistic response.

Investment = Loss Of Company Control

“If I take money from an investor they will want ownership of the company and then it will cease to be a woman-owned company. Something that is very important to me and at the core of our mission at Etain,” she said. Plus, it’s well known that women-owned companies have a harder time raising money than male-led companies. That is why women-owned funds have sprung up to help their peers, but Peckham noted that these funds wouldn’t be able to deliver the amount of money she needs.

NYS Loan Rejected

The next suggestion for Peckham was to borrow the money. Peckham did apply with the Community Economic Development Department for a loan but was rejected because she worked in cannabis. Rafael Salaberrios, Vice President of Economic Revitalization told Peckham in an email, “It was a very difficult decision for us to make, but after conversations with the New York State Department of Financial Services(DFS) it was concluded that JDA Is not equipped to handle the necessary monitoring required by the Feds on Marijuana projects. JDA does not have the expertise or the manpower DFS thinks is needed to move forward.”

NYMCIA Incubator Loan

The NYMCIA suggested that the group pony up for a fund to help women-owned and minority cannabis businesses in incubator money. On the surface, this sounds like a great idea. Unfortunately, the irony of the only woman-led company (there are no minority-owned cannabis companies in New York) putting money in a fund that she would then be asking to receive money from seemed to be lost on the remainder of the group. She was derided as “cheap” by one of the male members of the group. The proposed pledge was $2.5 million.

Her only option was to resign from the group in order to try to take advantage of the fund. “They didn’t seem to understand the inherent conflict of interest or that I would be donating to a fund and then turning around and asking for money from that fund. Not only that, the contribution to the fund was probably going to escalate,” said Peckham. She had joined the association by pledging $50,000 but was now being asked to bump that up to $2.5 million for the fund. In her resignation email, Peckham wrote, “Etain cannot commit to ongoing or escalating financial commitments for a program that creates conflicts for requirements…We must conserve our capital for targeted purposes to remain sustainable in this industry.”

NYMCIA Says Nothing

Adam Goers, Vice President of Corporate Affairs at Columbia Care, a multi-state operator that is expected to become a publicly traded company this year, is chairman of the NYMCIA. The group did not respond to a request for comment on Peckhams resignation. NYMCIA recently stated that it asked fellow MSO MedMen Enterprises Inc. (MMNFF) to resign from the Association following a lawsuit filed by the company’s former CFO James Parker, in which Parker alleged CEO Adam Bierman had made derogatory comments.

“The Association has a zero-tolerance discrimination policy for any of our members who engage in this type of despicable behavior,” NYMCIA representatives said in a letter addressed to Gov. Cuomo, state Senate majority leader Andrea Stewart-Cousins and Assembly speaker Carl Heastie. MedMen confirmed that it had not resigned from the group and was still a member. Of course, seeing Etain go under just means one less competitor for the group.


The Wholesale Market

Saving a female-led company is not only good for diversity, but it turns out it will be important to the entire New York cannabis company. Etain provides several companies with a quality product. Without her, they lose a provider. This is very important because several people have told Green Market Report that some New York cannabis companies have been bringing in product from out of state illegally. A claim that hasn’t been verified, but a review of a company’s cultivation square footage versus sales will answer that question, especially if the company isn’t buying the product from another New Yorker.

Just Say Sell

The nuclear option to just sell the company which also isn’t possible for Peckham. Once again the state in its vision for diversity stated that women-owned and minority businesses can only sell to another like-minded company. Since there are no other women-owned or minority-owned cannabis companies in New York, there is no one to sell to.


The State could insist on a residency requirement for the recreational licenses, which would help Etain. Or it could carve out recreational licenses for existing medical license holders that are not publicly traded companies. There seem to be options available for the state to protect the diversity it claims to want, so far it hasn’t pursued anything other than talk.

StaffMarch 8, 2019


In honor of International Women’s Day, we decided to put together a list of the women in the industry that have collectively moved the industry forward with all of their hard work. As we could not name them all, we would like to thank and celebrate all of the women who have dedicated their precious time to the advancement of cannabis globally. It is because of each one of these ladies that this industry remains in the lead above all others as far as female leadership is concerned.

This list is in no special order. Each one of these women provide a great contribution to the cannabis industry in their own unique and badass way:

The “List”:

  1. Mara Gordon
  2. Kristin Nevedal
  3. Ophelia Chong
  4. Jamie Cooper
  5. Tiffany Bowden
  6. Elise McDonough
  7. Rosie Mattio
  8. Kristin Jordan
  9. Nancy Birnbaum
  10. Ellie Siegel
  11. SaraMitra Payan
  12. Yvonne DeLaRosa Green
  13. Leslie La Duke Banionis
  14. Anh Solis
  15. Jayn Green
  16. Terre Cutrone-lowe
  17. Mara Felsen
  18. Melodye Montgomery
  19. Emily Paxhia
  20. Tracey Mason
  21. Tahira Rehmatullah
  22. Leslie Stern
  23. Karyn Wagner
  24. Jessica Versteeg
  25. Amy Fisher
  26. Kristin Heidelbach-Teramoto
  27. Eve Lentz
  28. Alison Draisin
  29. Pamela Squatch
  30. Amanda Ostrowitz
  31. Pamela Epstein
  32. Frannie Shulman
  33. Jennifer Price
  34. Larisa Bolivar
  35. Anne Kelson
  36. Karson Humiston
  37. Beth Stavola
  38. Bonita Money
  39. Jackee Stang
  40. Jamie Pearson
  41. Jessica Billingsley
  42. Jeannette Horton
  43. Kyra Reed
  44. Heather Sobel
  45. Saramitra Payan
  46. Nicole Pietrangelo
  47. Nancy Biderman
  48. Sheena Shiravi
  49. Shawna Mcgregor
  50. Gretchen Gailey
  51. Olivia Mannix
  52. Andrea Burnett
  53. Adelia Lorena Carrillo
  54. Jennifer Chan
  55. Sarah Harf
  56. Karen Paull
  57. Cyo Nystrom
  58. Gaynell Rogers
  59. Lori Ferrara
  60. Lindy Snider
  61. Karen Paull
  62. Wendy Robbins
  63. Mariah Dodson
  64. Vanessa Macias
  65. Kathleen Thibault
  66. Kerri Accardi
  67. Heidi Haller Groshelle
  68. Michelle Ross
  69. Kelley Usborne Bruce
  70. Tamara Lovemelots Anderson
  71. Christie Lunsford
  72. Cait Curley
  73. Emalee Hyde
  74. Erin Lumley
  75. Luna Stower
  76. Amber E. Senter
  77. Anna Valent
  78. Jennifer Skog
  79. Dr. Lakisha Jenkins
  80. Gia Moron
  81. Dr. Chanda Macias
  82. Rosa Cazares
  83. Shaleen Title
  84. Vivien Azer
  85. AC Braddock
  86. Dr. Suzanne Sisley
  87. Lori Glauser
  88. Jennifer Sanders
  89. Whitney Beatty
  90. Devon Soloniewicz
  91. Elisabeth Stahura
  92. Bethany Gomez
  93. Julia Jacobson
  94. Anne Fleshman
  95. Stormy Simon
  96. Anne Fleshman
  97. Rosie Rothrock
  98. Natalie Shaul
  99. Kimberly Dillon
  100. Jaene Leonard
  101. Ashley Kingsley
  102. Erica Daniels
  103. Erin Gore
  104. Kyra Hoffner
  105. Molly Peckler
  106. Amanda Reiman
  107. Taylor Blake-Massive
  108. Debby Goldsberry
  109. Parisa Rad
  110. Julie Weed
  111. Anne Donohoe
  112. Talia Rubin
  113. Eliza Nova Maroney
  114. Ashley Manta
  115. Lorna Donohoe

Thank you to all of the women who do so much in our industry day in and day out. Your work does not go unnoticed and is deeply appreciated.

Happy International Women’s Day to all women around the world!

Special shout out to our Green Market Report founders Debra Borchardt and Cynthia Salarizadeh on this day!

Debra BorchardtJanuary 23, 2019


Eaze just released its 2018 State of Cannabis report giving insight into the buying habits of cannabis consumers. Eaze is a Calfornia-based cannabis delivery software company with buying history from 450,000 cannabis shoppers who have used Eaze for its delivery software service along with 4,000 survey respondents.


Some of the key findings included the breakout year for CBD (cannabidiol) products and the increase in the number of women who have become cannabis consumers. The report called CBD the “darling” of 2018 after learning that CBD consumers nearly doubled in 2018 from 2.6% to 4.8%. Part of this could be attributed to the tsunami of CBD products hitting the market and the general acceptance of the product as being mostly legal. The 2018 Farm Bill legalized CBD derived from hemp. Baby boomers are driving the increased sales of CBD products with 8.4%  of that business coming from that age group.

Women, in particular, are drawn to making CBD purchases. The Eaze report said that “Their preferred products appear to be more ‘beginner’ friendly.” The CBD-only customers reported a variety of effects from taking the product. 61% reported relaxation, while 41% reported anxiety and stress relief, while 40% reported pain relief.


In 2015, women accounted for 25% of the cannabis market and that number has jumped to 38% in 2018. “Over the past year, the total number of women customers grew 92%,” said the report. It also suggested that at this rate, women could end up equaling men by the year 2022 for consumption.

Women were most likely to purchase edibles, drops, and topicals, while men tended to buy the traditional flower and concentrates.  Gummies and the biggest edibles seller followed by bites, chocolate bars, cookies, and mints, respectively. Women also tend to consume cannabis more for personal care and sleep, while men use it for at-home entertainment and sports or exercise.


The report also determined that cannabis consumers tended to give up other things once they began to make regular cannabis purchases. Millenials reduced alcohol consumption and the Gen Z folks either quit tobacco smoking entirely or at least cut it down. All demographics said they reduced their use of over-the-counter pain relievers and prescription pain medicines. Over the counter drug purchases fell by 71% and prescription painkillers fell by 35%.

It seems by consuming cannabis, people are focusing more on the benefits of wellness. Bad habits like alcohol and cigarettes drop as consumers look to cannabis to feel better and contribute to an overall wellness behavior.





Anne-Marie FischerNovember 28, 2018


Staying true to their goals to be part of a history-making company that believes in a world that celebrates diversity of thought, race, gender and background, Portland’s Cura Cannabis Solutions announced the hiring of two female executives to lead their global expansion.

To make this global expansion possible, Amy McClintick moves from Chief Operating Officer to Chief Expansion Officer, while Jenny Diggles joins the Cura team as Vice President of International Expansion.

Cura, the maker of the Select brand of cannabis oils, names itself as one of the largest cannabis companies in the world.

Now with a team of 505 employees after a recent hiring spree focusing on senior and mid-level professionals, Cura has been recognized as the fastest-growing cannabis company in Portland’s history by Portland Business Journal. This year, Cura was voted one of the top 100 companies to work for in Oregon by Oregon Business Magazine.

McClintick has been with Cura since its inception, beginning in sales and operations and growing within the company to occupy the role of Chief Operating Officer and now taking on this new role that will bring the Select brands to the globe. She brings in-depth knowledge of the cannabis industry, operations, compliance and regulation with a proven ability to fast-track the company into new markets to her new position.

“The role of Chief Expansion Officer allows me to apply my experience and expertise to take Cura to the next level,” McClintic said in a company press release. The goal for her leadership is to create a focused and powerful team of sales superstars achieving history-breaking numbers for the cannabis industry.

Diggles joins the Cura team with experience in business development, fundraising, investments, and marketing in the cannabis and technology industries. With her most recent role as President of Global Expansion at MacArthur Capital LLC, she has been at the forefront of Oregon’s cannabis movement since its inception.

“I’ve always been a person who jumps at the opportunity to build something great, and this role will allow me to do just that, in an industry I care deeply about,” said Diggles in a company press release, “I look forward to bringing the Cura’s ‘Everything is Possible’ values with us around the world.”

MJBizDaily released a report on women and minorities in the cannabis industry in 2015; at the time, women held 36% of leadership positions within the industry. The same report was updated in 2017, showing this number had fallen to 27%. McClintick and Diggles’ roles will be an example to the cannabis industry for tipping the scales to include more women in executive, global-reaching roles.

“The growth of Cura would not be possible without the work of an incredible team that we’ve carefully selected,” said President and Chief Executive Officer Cameron Forni in a press release issued prior to the recruitment of new executive positions. “One of the most exciting elements of Cura is that we continue to hire the most incredible people. It is those incredible people from diverse backgrounds, genders, and ethnicities that are helping the Select brand establish itself as an integral part of the future of cannabis.”

Private Placement

Cura  also announced that it has completed a private placement funding round of approximately $75 million.
Cura’s President and Chief Executive Officer Cameron Forni said, “Since our founding in 2015, Cura Partners has now attracted more than $125 million in private capital and we are on pace to generate sales in excess of $120 million in 2018. This latest capital raise included investments from leading cannabis industry institutional investors in North America, Europe, Asia, Australia and the United Kingdom, reflecting increasing global interest in the cannabis industry and, more specifically, in our unique strategy and growth opportunities. We plan to invest the proceeds in product development, brand marketing, leadership talent and operational infrastructure to drive demand and fulfillment capabilities in the increasing number of legal U.S. and International markets.”


Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

Back to Top

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.